AGTX Agentix Corp.

OTC Biological Products, (No Diagnostic Substances) NV CIK: 0001603345
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Agentix Corp exhibits critical financial distress with zero revenue, negative stockholders' equity of -3.5M, and minimal cash reserves of only 6.4K against 3.5M in liabilities. The company is burning cash at an unsustainable rate with -124.6K free cash flow and demonstrates no viable business operations or path to profitability.

Strengths

Risks

  • ! Zero revenue indicates complete absence of business operations
  • ! Negative equity of -3.5M represents technical insolvency and existential going concern risk
  • ! Cash position of 6.4K provides virtually no runway for operations or debt service
  • ! Operating losses of -390.9K with negative operating cash flow of -123.3K demonstrates unsustainable burn rate
  • ! Liabilities of 3.5M exceed total assets of 6.4K by 546x, indicating balance sheet collapse
  • ! Long-term debt of 85.0K represents unserviceable obligations relative to asset base
  • ! No insider purchases in 90 days suggests lack of confidence from management

Key Metrics to Watch

Financial Metrics

Revenue
0.0
Net Income
-408.5K
EPS (Diluted)
$0.01
Free Cash Flow
-124.6K
Total Assets
6.4K
Cash
6.4K

Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -6,387.2%
FCF Margin N/A

Balance Sheet & Liquidity

Current Ratio
0.00x
Quick Ratio
-0.01x
Debt/Equity
N/A
Debt/Assets
54,790.4%
Interest Coverage
-6.60x
Long-term Debt
85.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-19T17:40:53.065429 | Data as of: 2025-12-31 | Powered by Claude AI